BR0207978A - N-but-3enil norbuprenorfina e métodos de uso - Google Patents

N-but-3enil norbuprenorfina e métodos de uso

Info

Publication number
BR0207978A
BR0207978A BR0207978-0A BR0207978A BR0207978A BR 0207978 A BR0207978 A BR 0207978A BR 0207978 A BR0207978 A BR 0207978A BR 0207978 A BR0207978 A BR 0207978A
Authority
BR
Brazil
Prior art keywords
methods
treating
norbuprenorphine
3enyl
compound
Prior art date
Application number
BR0207978-0A
Other languages
English (en)
Inventor
Bruce E Reidenberg
Donna-Donigi Gale
Vinayak J Srinivasan
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of BR0207978A publication Critical patent/BR0207978A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"N-BUT-3-ENIL NORBUPRENORFINA E MéTODOS DE USO". A invenção presente provê um composto tendo a estrutura e sais farmaceuticamente aceitáveis ou derivados do mesmo, assim como composições incluindo tais compostos. A invenção provê também métodos para (1) impedir a dor, (2) tratar a dor, (3) induzir sedação, (4) tratar dependência opiácea, (5) tratar abstinência opiácea (síndrome de abstinência) e/ou (6) tratar a tosse num paciente necessitando dos mesmos administrando um composto ou composição da invenção.
BR0207978-0A 2001-03-02 2002-03-04 N-but-3enil norbuprenorfina e métodos de uso BR0207978A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27281901P 2001-03-02 2001-03-02
PCT/US2002/006766 WO2002070524A2 (en) 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic

Publications (1)

Publication Number Publication Date
BR0207978A true BR0207978A (pt) 2004-03-02

Family

ID=23041438

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207978-0A BR0207978A (pt) 2001-03-02 2002-03-04 N-but-3enil norbuprenorfina e métodos de uso

Country Status (14)

Country Link
US (2) US7125884B2 (pt)
EP (1) EP1368356A2 (pt)
JP (1) JP2004538256A (pt)
KR (1) KR20030088445A (pt)
CN (1) CN1507448A (pt)
BR (1) BR0207978A (pt)
CA (1) CA2439859A1 (pt)
IL (1) IL157662A0 (pt)
MX (1) MXPA03007885A (pt)
NO (1) NO20033854L (pt)
NZ (1) NZ528241A (pt)
RU (1) RU2003129531A (pt)
WO (1) WO2002070524A2 (pt)
ZA (1) ZA200307337B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
KR101343395B1 (ko) 2008-07-30 2013-12-19 퍼듀 퍼머 엘피 부프레노르핀 유사체
HUE027195T2 (en) 2010-09-21 2016-10-28 Purdue Pharma Lp Buprenorphine analogues as opioid receptor agonists and / or antagonists
WO2013084060A1 (en) * 2011-12-08 2013-06-13 Purdue Pharma L.P. Quaternized buprenorphine analogs
RU2506265C1 (ru) * 2012-08-21 2014-02-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Фторсодержащие производные тевинола и орвинола и способы их получения (варианты)
RU2503678C1 (ru) * 2012-08-21 2014-01-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 7α-(1-ГИДРОКСИ-2,2,2-ТРИФТОРЭТИЛ)-17-МЕТИЛ-3,6-ДИМЕТОКСИ-4,5α-ЭПОКСИ-6α,14αЭТЕНОИЗОМОРФИНАН И СПОСОБ ЕГО ПОЛУЧЕНИЯ
WO2014072809A2 (en) 2012-11-09 2014-05-15 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
AR094641A1 (es) 2012-12-07 2015-08-19 Purdue Pharma Lp Análogos de buprenorfina
TW201441199A (zh) * 2012-12-28 2014-11-01 Purdue Pharma Lp 經取代之嗎啡喃類及其用途
US9056836B2 (en) 2013-01-31 2015-06-16 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097547A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 10-substituted morphinan hydantoins
EP3087079B1 (en) 2013-12-26 2019-04-03 Purdue Pharma LP Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
WO2015097548A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
CA2934913A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
US10550088B2 (en) 2013-12-27 2020-02-04 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
US10030021B2 (en) 2014-05-27 2018-07-24 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
CA2951697A1 (en) 2014-06-13 2015-12-17 Purdue Pharma L.P. Azamophinan derivatives and use thereof
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CA2319627A1 (en) 1998-01-29 1999-08-05 Polychip Pharmaceuticals Pty. Ltd. Therapeutic compounds

Also Published As

Publication number Publication date
NZ528241A (en) 2004-08-27
US20040087605A1 (en) 2004-05-06
NO20033854D0 (no) 2003-09-01
MXPA03007885A (es) 2004-05-24
RU2003129531A (ru) 2005-04-10
ZA200307337B (en) 2004-12-20
JP2004538256A (ja) 2004-12-24
CN1507448A (zh) 2004-06-23
WO2002070524A3 (en) 2002-10-17
KR20030088445A (ko) 2003-11-19
WO2002070524A2 (en) 2002-09-12
CA2439859A1 (en) 2002-09-12
US7125884B2 (en) 2006-10-24
NO20033854L (no) 2003-10-28
US20050192308A1 (en) 2005-09-01
IL157662A0 (en) 2004-03-28
EP1368356A2 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
BR0207978A (pt) N-but-3enil norbuprenorfina e métodos de uso
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
BRPI0415007A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
DK1265630T3 (da) Anvendelse af insulin til behandling af brusksygdomme
BR0210652A (pt) Pirrolopirimidinas como inibidores de proteìnas cinases
BR0114610A (pt) Composto, uso do mesmo, e, composição farmacêutica
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR0211289A (pt) Derivados de dolastatina 10
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
EA199901014A1 (ru) C-4"-замещенные макролидные производные
BR0315580A (pt) Derivados de metileno uréia
BRPI0410049A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
BR9908470A (pt) Composto, composição farmacêutica, e, processo para tratar condições mediadas pela inegrina avb3 em um mamìfero em necessidade de tal tratamento
SE9802208D0 (sv) Novel compounds
BR9908125A (pt) Composto, composto dimérico, composição farmacêutica, uso do composto, processo compreendendo inibir células de câncer, e, processo terapêutico
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
SE9902267D0 (sv) New compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]